EPA091 | Immunogenicity of mRNA-1273 COVID-19 vaccination in PLWH after inadequate primary vaccination response | E-poster | SARS-Cov2 vaccines |
EPB048 | Immunogenicity and safety of yellow fever vaccination in people living with HIV | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
EPA011 | Immune preservation in HIV+ Viremic Non-Progressors is associated with downregulation of type-I IFN pathway and reduced activation of cytotoxic compartments | E-poster | Systemic immune activation and inflammation |
EPA007 | Immune correlates of cell-associated HIV RNA levels in infected individuals undergoing long-term antiretroviral therapy | E-poster | Viral fitness, persistence and resistance |
OALBA0102 | Immune correlates analysis of the Imbokodo HIV-1 vaccine efficacy trial | Oral abstract session with live Q&A | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |
EPE044 | I'm Ready Research Program: Outcomes from the first 6 months of the first national HIV self-testing program in Canada to reach the undiagnosed and link them to care | E-poster | Implementation science of scaling up HIV testing |
EPLBA08 | ILC3s in HIV-infected lymph nodes up-regulate inflammatory pathways linked to tissue fibrosis | E-poster | Innate immunity (including NK cells) |
EPA016 | IL-32γ induces the expression of a heart-homing signature on a subset of memory CD4 T-cells with increased permissiveness to HIV-1 infection: a potential role in cardiovascular disease | E-poster | Systemic immune activation and inflammation |
EPB093 | IL-32 isoforms differentially impact coronary artery endothelium functions and potential to recruit inflammatory cells | E-poster | Cardiovascular disease |
PESUF21 | If not now, when? A unique opportunity to reduce HIV-related stigma & discrimination, criminalization & other human rights-related barriers | Poster exhibition | Human rights of people living with HIV and key populations |